Sunitinib malate

• Catalog No.: PZ0012
• CAS Number: 341031-54-7
• M. F.: C26H33FN4O7
• M. W.: 532.5612232
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: (2S)-2-hydroxybutanedioic acid; N-[2-(diethylamino)ethyl]-5-[(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
• IUPAC Traditional name: (-)-malic acid; sunitinib
• Synonyms: N-[2-(Diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-2-hydroxybutanedioic acid (1:1) salt; SU 11248; SU 011248; SU112248

DATABASE IDS

• MDL Number: MFCD08282795
• CAS Number: 341031-54-7

PROPERTIES

• Empirical Formula (Hill Notation): C22H27FN4O2 · C4H6O5
• Purity: ≥98% (HPLC)
• Apperance: powder
• Solubility: DMSO: >10 mg/mL
• GHS Signal Word: Danger
• GHS Hazard statements: H360-H372
• European Hazard Symbols: Toxic (T)
• GHS Precautionary statements: P201-P308 + P313
• Risk Statements: 61-2-48/25
• Safety Statements: 53-22-36/37
• Storage Temperature: room temp
• German water hazard class: 2

DETAILS

Description (English)

Biochem/physiol Actions
Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.

Description (简体中文)

Biochem/physiol Actions
Sunitinib malate is a receptor tyrosine kinase inhibitor, which targets VEGF-R1, VEGF-R2, VEGF-R3, PDGF-Rα, PDGF-Rβ, KIT, FLT3, CSF-1R, and RET. Sunitinib malate is an anticancer drug.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.